View On IC.GC.CA

CANCELLED

Last Applicant/ Owned by

Affinivax, Inc.

Corporation Service Company,251 Little Falls DriveWilmington DE 19808

Serial Number

2109764 filed on 23^rd Feb 2021

Registration Number

TMA1228771 registered on 11^th Apr 2024

Registration expiry Date

23^rd Feb 2031

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

K1P1J9

AV

Trademark usage description

vaccines for human use; vaccines for the prophylaxis and treatment of infectious diseases and cancer; vaccines, namely, pharmaceutical preparations fo Read More

Vienna Information

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 22

Monograms formed of intertwined, overlapping or otherwise combined lettersMonogrammes formés par des lettres enlacées, se chevauchant ou combinées autrement

1 . 15 . 15

DropsGouttes

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

29 . 1 . 5

VioletViolet

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

Classification Information

Class [005]
Vaccines for human use; vaccines for the prophylaxis and treatment of infectious diseases and cancer; vaccines, namely, pharmaceutical preparations for use in immunotherapies for the treatment of infectious diseases and cancer; vaccines comprising polysaccharide antigens and protein-based antigens; vaccines, namely, pharmaceutical preparations for use in immunotherapies comprising polysaccharide antigens and protein-based antigens.

Classification kind code

Class [042]
Research and development services in the field of vaccines; research and development services in the field of vaccines for the prophylaxis and treatment of infectious diseases and cancer; research and development services in the field of vaccines, namely, pharmaceutical preparations for use in immunotherapies for the treatment of infectious diseases and cancer; research and development in the field of vaccines comprising polysaccharide antigens and protein-based antigens; research and development in the field of vaccines, namely, pharmaceutical preparations for use in immunotherapies comprising polysaccharide antigens and protein-based antigens.

Classification kind code

Mark Details

Serial Number

2109764

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 13^th Sept 2022	Search Recorded
Submitted for opposition 20 on 13^th Sept 2022	Examiner's First Report
Submitted for opposition 223 on 13^th Sept 2022	Total Provisional Refusal
Submitted for opposition 256 on 28^th Mar 2022	Notification of Possible Opposition Sent
Submitted for opposition 48 on 17^th Nov 2021	Agent Changed
Submitted for opposition 257 on 27^th May 2021	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 26^th May 2021	Formalized
Submitted for opposition 1 on 26^th May 2021	Created
Submitted for opposition 228 on 23^rd Feb 2021	International Registration
Submitted for opposition 30 on 23^rd Feb 2021	Filed